Profile data is unavailable for this security.
About the company
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Company’s products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.
- Revenue in CNY (TTM)151.84bn
- Net income in CNY2.17bn
- Incorporated1999
- Employees30.14k
- LocationJointown Pharmaceutical Group Co LtdNo. 8, Longyang Avenue, Hanyang DistrictWUHAN 430051ChinaCHN
- Phone+86 2 784683017
- Fax+86 2 784451256
- Websitehttp://www.jztey.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guangxi LiuYao Group Co Ltd | 20.45bn | 800.82m | 7.67bn | 5.16k | 9.58 | 1.18 | -- | 0.3752 | 2.21 | 2.21 | 56.44 | 17.97 | 1.02 | 7.66 | 1.96 | 3,961,076.00 | 4.36 | 5.37 | 11.45 | 12.66 | 11.26 | 11.68 | 4.27 | 4.48 | 1.26 | 6.34 | 0.5641 | 30.45 | 11.19 | 15.06 | 24.42 | 11.81 | -0.6923 | 8.57 |
| Tibet Rhodiola Pharmaceutical Holding Co | 3.13bn | 800.91m | 11.44bn | 601.00 | 14.28 | 3.42 | -- | 3.65 | 3.23 | 3.23 | 12.64 | 13.49 | 0.7216 | 1.83 | 5.71 | 5,215,189.00 | 18.65 | 12.44 | 25.21 | 15.71 | 93.83 | 90.51 | 25.85 | 20.43 | 2.78 | 7.59 | 0.1294 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.11bn | -324.42m | 11.71bn | 1.95k | -- | 6.78 | -- | 10.54 | -0.6628 | -0.6628 | 2.27 | 3.53 | 0.4005 | 0.8061 | 1.31 | 569,846.60 | -12.26 | -1.17 | -16.80 | -1.67 | 69.24 | 71.94 | -30.62 | -3.27 | 1.55 | -18.71 | 0.1474 | -- | 16.44 | -3.17 | -26.08 | -- | -50.29 | -- |
| China Meheco Group Co Ltd | 40.47bn | 563.10m | 16.71bn | 8.31k | 29.67 | 1.49 | -- | 0.4129 | 0.3764 | 0.3764 | 27.05 | 7.48 | 1.13 | 5.58 | 2.76 | 4,868,542.00 | 2.05 | 4.09 | 4.44 | 9.37 | 11.07 | 15.92 | 1.81 | 3.38 | 1.16 | 21.23 | 0.3262 | 38.19 | 3.75 | 4.37 | 13.70 | -10.94 | 12.63 | -4.53 |
| China National Medicines Corp Ltd | 49.70bn | 2.15bn | 26.69bn | 3.14k | 12.44 | 1.69 | -- | 0.5372 | 2.84 | 2.84 | 65.87 | 20.91 | 1.60 | 11.93 | 6.76 | 15,836,850.00 | 7.52 | 7.32 | 14.58 | 15.03 | 7.80 | 8.15 | 4.70 | 4.31 | 1.75 | -- | 0.1526 | 30.04 | 9.23 | 5.11 | 9.26 | 8.85 | 1.84 | 16.38 |
| Jointown Pharmaceutical Group Co Ltd | 151.84bn | 2.17bn | 33.07bn | 30.14k | 15.31 | 1.40 | -- | 0.2178 | 0.5524 | 0.5524 | 38.85 | 6.06 | 1.63 | 9.43 | 4.08 | 5,037,721.00 | 2.40 | 3.04 | 8.03 | 9.58 | 7.76 | 8.35 | 1.47 | 2.04 | 0.9936 | 3.71 | 0.573 | 41.91 | 14.72 | 13.69 | -14.91 | 9.14 | 2.66 | 37.97 |
| Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 75.52bn | 4.06bn | 47.27bn | 28.05k | 12.31 | 1.43 | -- | 0.6259 | 2.49 | 2.49 | 46.45 | 21.48 | 0.9855 | 5.56 | 5.04 | 2,692,363.00 | 5.56 | 5.90 | 11.17 | 12.40 | 18.33 | 18.70 | 5.64 | 5.56 | 1.23 | -- | 0.3013 | 30.02 | 6.68 | 12.32 | 2.25 | 3.34 | 27.75 | 12.05 |
| Shanghai Pharmaceuticals Holding Co Ltd | 260.30bn | 3.77bn | 57.83bn | 48.16k | 17.10 | 0.9447 | -- | 0.2222 | 1.02 | 1.02 | 70.33 | 18.50 | 1.27 | 6.46 | 3.73 | 5,404,350.00 | 2.52 | 3.53 | 6.70 | 9.34 | 11.75 | 13.21 | 1.98 | 2.66 | 1.03 | 7.59 | 0.4351 | 32.89 | 12.21 | 10.35 | -32.92 | -0.5896 | 8.86 | 0.00 |
Data as of Apr 19 2024. Currency figures normalised to Jointown Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 35.19m | 0.90% |
| Morgan Stanley Huaxin Fund Management Co., Ltd.as of 30 Jun 2023 | 28.57m | 0.73% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 20.97m | 0.54% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2023 | 13.75m | 0.35% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 10.46m | 0.27% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2023 | 10.21m | 0.26% |
| Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 2023 | 7.73m | 0.20% |
| AllianceBernstein (Singapore) Ltd.as of 28 Mar 2024 | 6.28m | 0.16% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 6.07m | 0.16% |
| Goldman Sachs Asset Management LPas of 11 Apr 2024 | 5.89m | 0.15% |
More ▼
Data from 30 Jun 2023 - 28 Mar 2024Source: FactSet Research Systems Inc.
